Redmile as of Sept. 30, 2012
Portfolio Holdings for Redmile
Redmile holds 51 positions in its portfolio as reported in the September 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 8.9 | $31M | 472k | 66.33 | |
Onyx Pharmaceuticals | 7.8 | $27M | 324k | 84.50 | |
Ariad Pharmaceuticals | 7.6 | $27M | 1.1M | 24.21 | |
Dynavax Technologies Corporation | 5.2 | $18M | 3.8M | 4.76 | |
Align Technology (ALGN) | 4.1 | $15M | 395k | 36.97 | |
Celgene Corporation | 4.1 | $14M | 189k | 76.40 | |
Medivation | 4.0 | $14M | 248k | 56.35 | |
St. Jude Medical | 4.0 | $14M | 331k | 42.13 | |
Bristol Myers Squibb (BMY) | 3.9 | $14M | 411k | 33.75 | |
Conceptus | 3.6 | $13M | 625k | 20.31 | |
ArthroCare Corporation | 3.1 | $11M | 335k | 32.40 | |
Allergan | 2.8 | $9.9M | 108k | 91.58 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.6 | $9.4M | 168k | 55.89 | |
Ym Biosciences | 2.4 | $8.5M | 4.6M | 1.84 | |
NuVasive | 2.4 | $8.4M | 366k | 22.91 | |
Salix Pharmaceuticals | 2.4 | $8.3M | 197k | 42.34 | |
Amicus Therapeutics (FOLD) | 2.3 | $8.0M | 1.5M | 5.20 | |
Momenta Pharmaceuticals | 2.0 | $7.0M | 483k | 14.57 | |
Exelixis (EXEL) | 1.9 | $6.9M | 1.4M | 4.83 | |
Trius Therapeutics | 1.9 | $6.5M | 1.1M | 5.83 | |
Elan Corporation | 1.8 | $6.2M | 577k | 10.72 | |
BioSpecifics Technologies | 1.7 | $6.0M | 311k | 19.42 | |
Nektar Therapeutics (NKTR) | 1.7 | $5.9M | 550k | 10.68 | |
WellCare Health Plans | 1.6 | $5.8M | 102k | 56.55 | |
Cutera (CUTR) | 1.6 | $5.7M | 763k | 7.46 | |
Orthofix International Nv Com Stk | 1.5 | $5.4M | 121k | 44.75 | |
Sanofi Aventis Wi Conval Rt | 1.5 | $5.4M | 3.2M | 1.68 | |
Neurocrine Biosciences (NBIX) | 1.4 | $4.9M | 617k | 7.98 | |
Cardinal Health (CAH) | 1.4 | $4.8M | 123k | 38.97 | |
HeartWare International | 1.3 | $4.7M | 50k | 94.50 | |
MAKO Surgical | 1.1 | $4.0M | 229k | 17.41 | |
Clovis Oncology | 1.1 | $3.8M | 185k | 20.45 | |
Vanguard Health Systems | 1.0 | $3.4M | 278k | 12.37 | |
D Fluidigm Corp Del (LAB) | 0.7 | $2.6M | 154k | 17.00 | |
TranS1 (TSON) | 0.7 | $2.4M | 925k | 2.64 | |
Hyperion Therapeutics | 0.6 | $2.1M | 200k | 10.63 | |
Exelixis Inc cnv | 0.6 | $2.0M | 2.0M | 1.00 | |
Anthera Pharmaceuticals | 0.5 | $1.7M | 1.8M | 0.99 | |
Tesaro | 0.5 | $1.6M | 111k | 14.23 | |
Cyclacel Pharmaceuticals | 0.3 | $1.1M | 764k | 1.42 | |
Array BioPharma | 0.2 | $888k | 152k | 5.84 | |
Accuray Inc Del note 3.750% 8/0 | 0.1 | $500k | 500k | 1.00 | |
Intuitive Surgical (ISRG) | 0.1 | $248k | 500.00 | 496.00 | |
McKesson Corporation (MCK) | 0.1 | $172k | 2.0k | 86.00 | |
Harvard Bioscience (HBIO) | 0.0 | $106k | 25k | 4.24 | |
Orexigen Therapeutics | 0.0 | $76k | 13k | 5.71 | |
Idenix Pharmaceuticals | 0.0 | $67k | 15k | 4.56 | |
Healthsouth | 0.0 | $60k | 2.5k | 24.00 | |
Agenus (AGEN) | 0.0 | $58k | 13k | 4.64 | |
Spectrum Pharmaceuticals | 0.0 | $6.0k | 500.00 | 12.00 | |
Pacific Biosciences of California (PACB) | 0.0 | $2.0k | 951.00 | 2.10 |